Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POWER II: Pre-Operative Window of Endocrine Therapy in Older Women With Early-Stage Breast Cancer
NCT06507618Phase 3Recruiting
- Sponsor
- University of Virginia
- Start
- Jul 2024
- Primary completion
- Jun 2029
- Countries
- 1
01
Overview
A Phase 3 trial of tamoxifen, letrozole, anastrozole, exemestane in breast cancer, sponsored by University of Virginia. Started Jul 2024; status: recruiting.
02
Drugs
tamoxifenletrozoleanastrozoleexemestane
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT06507618.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06507618.